Obesity represents a well-known risk factor for renal cell carcinoma development. Several
studies evaluated the relationship between obesity and outcome in patients with non …

Liquid biopsy—the determination of circulating cells, proteins, DNA or RNA from biofluids
through a “less invasive” approach—has emerged as a novel approach in all cancer entities …

Backgrounds/Aims. Watson for Oncology (WFO) is a cognitive technology that processes
medical information by analyzing the latest evidence and guidelines. However, studies of …

Background Sunitinib malate, a targeted tyrosine kinase inhibitor, is standard of care for
metastatic renal cell carcinoma (mRCC) and serves as the active comparator in several …

Abstract Background The International Metastatic Renal Cell Carcinoma Database
Consortium (IMDC) criteria are the gold standard for risk‐stratifying patients with metastatic …

Objectives To evaluate the effect of pretreatment C‐reactive protein/albumin ratio and
modified Glasgow prognostic score on the prognosis in patients with metastatic renal cell …

Background Patients with metastatic renal cell carcinoma (mRCC) treated with targeted
systemic therapies have demonstrated favourable outcomes in randomised controlled trials …

Abstract Purpose The International Metastatic Renal Cell Carcinoma Database Consortium
(IMDC) risk model has been designed for prognostification in patients with metastatic renal …

Background: Scoring systems are a method of risk assessment used to stratify patients with
metastatic renal cell carcinoma (mRCC) and guide systemic therapy. The variables are …

Purpose To investigate the impact of the risk group disagreement between the Memorial
Sloan Kettering Cancer Center (MSKCC) and the International Metastatic Renal Cell …